Kercheville Advisors, LLC Immuno Gen, Inc. Transaction History

Kercheville Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	SELL	$12.46 - $29.95 $20,932 - $50,316	-1,680 Reduced 1.44%	114,897 $3.41 Million
Q3 2023 Oct 11, 2023	SELL	$14.09 - $19.87 $837,833 - $1.18 Million	-59,463 Reduced 33.78%	116,577 $1.85 Million
Q2 2023 Jul 20, 2023	SELL	$3.75 - $20.05 $286,920 - $1.53 Million	-76,512 Reduced 30.3%	176,040 $3.32 Million
Q1 2023 Apr 06, 2023	SELL	$3.67 - $4.92 $95,695 - $128,289	-26,075 Reduced 9.36%	252,552 $969,000
Q4 2022 Feb 13, 2023	BUY	$4.55 - $6.31 $183,478 - $254,450	40,325 Added 16.92%	278,627 $1.38 Million
Q3 2022 Oct 17, 2022	BUY	$4.48 - $6.47 $4,928 - $7,117	1,100 Added 0.46%	238,302 $1.14 Million
Q2 2022 Jul 18, 2022	BUY	$3.15 - $5.76 $33,390 - $61,056	10,600 Added 4.68%	237,202 $1.07 Million
Q1 2022 Apr 29, 2022	BUY	$4.26 - $7.48 $84,987 - $149,226	19,950 Added 9.65%	226,602 $1.08 Million
Q4 2021 Jan 26, 2022	BUY	$4.75 - $7.5 $80,512 - $127,125	16,950 Added 8.94%	206,652 $1.53 Million
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $36,646 - $48,107	-7,300 Reduced 3.71%	189,702 $1.08 Million
Q2 2021 Nov 15, 2021	BUY	$5.79 - $8.6 $18,800 - $27,924	3,247 Added 1.68%	197,002 $1.3 Million
Q1 2021 Nov 15, 2021	SELL	$6.5 - $10.53 $329,329 - $533,512	-50,666 Reduced 20.73%	193,755 $1.56 Million
Q4 2020 Nov 12, 2021	BUY	$3.7 - $7.66 $904,357 - $1.87 Million	244,421 New	244,421 $1.56 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Kercheville Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kercheville Advisors, LLC with notifications on news.